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Abstract 
Telecare is a healthcare resource based on new technologies that, through the services offered, attempt to help 
elderly people to continue living in their homes. In this sense, first-generation telecare services have quickly 
developed in Europe. The aim of this work was to define the profile, pattern of medication consumption and 
disease frequencies of elderly users of a telecare service. The cross-sectional study involved 742 Spanish 
community-dwelling elders (85.3% of the total users aged 65 years and over who used a telecare service 
before the end of the data collection period). Data were collected between March and September 2012. 
Subjects’ mean age was 83.3 (SD 6.6) years, and the majority lived alone (78.3%) and were female (85.8%). 
The mean Charlson comorbidity index score was 1.13 (SD 1.1), and the mean number of prescribed 
medications per day was 5.6 (SD 3.0). The most frequent diseases were hypertension (51.1%) and rheumatic 
disorders (44%); and the most consumed medications were those for the cardiovascular (75%) and nervous 
(65.2%) systems. For the total sample, the three main determinants of polymedication (five or more 
medications) were hypertension, anxiety-depressive symptoms and coronary heart disease. Regardless of the 
social elements contributing to the implementation of telecare services, specific health characteristics of 
potential users, such as morbidity and polypharmacy, should be carefully considered when implementing 
telecare services in the coming years. 
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Introduction 
Current population estimates highlight the increasing trend of elderly individuals over 60 years. 
In fact, this population is expected to increase by 22% by 2030 (Bloom et al. 2014). In Europe, 
people aged 65 and over represent 17.9% of the population (Eurostat, 2015), and this percentage 
rises to 18.3% in Spain and to 23.7% in Galicia (Spanish Statistical Office [Instituto Nacional de 
Estadística] 2014), an autonomous community in the northwest of Spain. This increase implies 
significant changes to the national health services to address this demographic change (Brown 
2003). Ageing is characterised by a decrease in individuals’ functional capacity, with the decrease 
varying by age and sex (Spanish Statistical Office [Instituto Nacional de Estadística] 2008, Millán-
Calenti & Maseda 2011). Furthermore, ageing is associated with an increased difficulty in 
adapting to external requirements and increased likelihood of becoming ill (Millán-Calenti & 
Maseda 2011), thus leading to a need for caring support. In the majority of cases, such support will 
be provided by the family circle through ‘informal caregivers’. In Spain, 32% of the population 
over 65 have some type of disability, and among them, 55.8% are dependent on others to perform 
daily activities (Spanish Statistical Office [Instituto Nacional de Estadística] 2008). 
 
This increase in terms of the number, health status and life expectancy of older people, coupled 
with the decrease in the number of families with the financial capacity to pay for care, has resulted 
in and will continue to result in significant consequences for socioeconomic and health factors. 
Therefore, both the public and private sectors have sought to develop formulas that, as far as 
possible, help to alleviate the current needs and to plan for the near future given that ‘prevention is 
better than cure’; such prevention is the aim of telecare (Brown 2003). In this sense, in the early 
1990s, and as a result of the evolution of the new technologies applied (Valero et al. 2007), 
telecare and telehealth services arose. These services have evolved considerably from the first 
generation to the third generation (Kubitschke et al. 2010, Parker & Hawley 2013). Sixsmith et al. 
(2007) define the telecare classifications as follows: A ‘first generation’ of telecare refers to 
community alarms that are widely used by elderly and vulnerable individuals to raise an alert 
when assistance is required. The ‘second generation’ includes smart sensors that incorporate a 
degree of intelligence to monitor and interpret a person's movements and automatically raise an 
alarm even if the person is incapacitated and unable to do it himself. The ‘third generation’ 
involves intelligence within non-PC products and devices so that everyday appliances and 
electronic environments can communicate with each other and transform digital technology into an 
integral and intuitive part of daily life. As a consequence of this evolution, telecare service has 
become a home support system (Barlow et al. 2007, Botsis et al. 2008, Daniel et al. 2009, 
Milligan et al. 2011, Parker & Hawley 2013, Sintonen & Immonen 2013). Based on the portfolio 
of services offered, call receivers try to meet the current need by themselves or by mobilising other 
human or material resources (Galimany-Masclans et al. 2011), providing obvious benefits to the 
user (i.e. quality of life), informal caregiver (i.e. providing reassurance), professional caregiver 
(i.e. additional options for care), statutory services (i.e. avoidance of hospital admission), industry 
(i.e. new market opportunities) and government (i.e. save money associated with care; Audit 
Commission, 2004; Davies et al. 2013). Furthermore, such services provide benefits to healthcare 
systems in the sense of decreasing service demand and hospital institutionalisations (Department 
of Health, 2011). More financial support will be necessary to enhance the introduction of new 
telecare services for the care of elderly people while bearing in mind the fact that future success 
will depend on new technologies’ ability to support family caregivers, as opposed to replacing 
them (Callan & O'Shea 2015). The user has to make a ‘cost–benefit’ analysis by considering that 
there could be a loss of privacy but gains in mobility, safety, self-determination and empowerment 
(Melander-Wikman et al. 2008). 
 
At the European level, Spain (791,180 users; IMSERSO 2014) is among the countries with an 
estimated moderate take-up level (first generation), including France and Italy, among others (1–
3% of older people). Coverage is high in Denmark and Finland (6–10%) and very high (14–16%) 
in the United Kingdom and Ireland; by contrast, it is low (<1%) in Portugal and Belgium, among 
others. The forecasts are that the potential market for telecare and telehealth services will 
experience substantial growth in Europe in the coming years (Kubitschke et al. 2010). New 
technologies can be viewed as simply another resource to be employed alongside family and 
friends, community organisations and local media. Furthermore, such technologies have the ability 
to rapidly create local, national and global networks around specific issues that may provoke a 
radical shift in the way health systems function (Lucas 2008). 
 
In this sense, a number of previous reviews have examined the beneficial aspects of telecare 
and telehealth from the economic point of view, but few have focused specifically on the users’ 
characteristics to describe who actually uses telecare services analysing a large sample size. This is 
in line with research by Finch et al. (2007), suggesting that if telehealth care is to become patient-
centred, knowledge of users’ priorities and preferences is needed. Besides, in the present study, we 
will quantify the magnitude of differences (effect size) found between the groups to establish the 
power to support our hypothesis. Therefore, the objective of this work was to define the health 
profile and to examine the gender and age differences of the users of a first-generation telecare 
public service to deepen our knowledge of their health status, which will enable telecare 
developers to acquire a detailed understanding of the users’ needs. 
Methods 
Study design and participants 
A retrospective, cross-sectional, descriptive study was conducted between March and 
September 2012 with a sample of older people aged 65 years and over who used a first-generation 
telecare service provided by the A Coruña City Council as a concerted entity. To be eligible, from 
the 850 telecare users, potential participants had to fulfil the inclusion criteria defined in Figure 1. 
A Coruña is the second largest city in Galicia (in north-western Spain). Participants were all users 
registered in the service database before the end of the data collection period (1 September 2012). 
 
 
 
Figure 1. Flow chart, study protocol. EphMRA, European Pharmaceutical 
Marketing Research Association. 
  
Ethics approval for the study was obtained by the Ethics Committee of the participating 
university, and the study conforms to the Declaration of Helsinki, which requires all users to sign 
informed consent forms, being completed during the telecare registration process. 
Service description 
The service, first-generation telecare operating 24 hours per day and 365 days per year, 
consists of a telephone signal transmitter/receiver unit and a button (pendant or bracelet) that the 
user carries at all times. If help is needed, the user presses the button and a telephone call is 
established with a control centre that identifies the user and visualises the registered data to 
diagnose the current situation and its urgency and mobilise the required resources. On a regular 
basis, the service calls the user to monitor the user's state. 
Data collection and instruments 
The data for this study were collected from the telecare registration programme (Figure 1). 
Users’ information was entered by a social worker (personal and sociodemographic data) and by 
their general practitioner (health data). Personal and sociodemographic data included age, sex and 
family arrangements (the person lives alone, lives with relatives or does not live with relatives, 
missing data: 11/742 cases, 1.5%). Health data were also gathered, such as clinical diagnosis 
[missing data: between 10.4% (77/742 cases) and 11.7% (87/742 cases)], medication consumption 
(missing data: 21/742 cases, 2.8%), fall history (missing data: 40/742 cases, 5.4%) and presence of 
disability (missing data: 333/742 cases, 44.9%) and/or dependence (missing data: 289/742 cases, 
38.9%). Missing data were due to incomplete or poor information in the telecare registration 
programme. 
 
Clinical diagnoses were coded according to the Charlson comorbid diseases (Charlson et al. 
1987), a method of classifying prognostic comorbidity in a geriatric population. We used a proxy 
(Gutiérrez-Misis et al. 2012) of the Charlson comorbidity index (CCI) to include myocardial 
infarct and congestive heart failure into one category: coronary heart disease. In addition, other 
prevalent diagnoses were included: hypertension, rheumatic disorders (osteoporosis and arthrosis), 
anxiety-depressive symptoms, dizziness/vertigo and digestive problems. 
 
The medications that participants consumed were classified according to the Anatomical 
Classification of Pharmaceutical Products developed by the EphMRA (2014). This classification 
includes 16 main divisions: Alimentary tract and metabolism; Blood and blood-forming organs; 
Cardiovascular system; Dermatologicals; Genito-urinary system and sex hormones; Systemic 
hormonal preparations (excluding sex hormones); General anti-infectives systemic; Hospital 
solutions; Antineoplastic and immunomodulating agents; Musculo-skeletal system; Nervous 
system; Parasitology; Respiratory system; Sensory organs; Diagnostic agents; and Various. 
Polypharmacy or polymedication was defined as the concomitant use of five or more different 
prescription medications (Gnjidic et al. 2012). 
 
To determine the risk of falls, the Downton Index (Downton 1993) was completed for every 
user based on data obtained from the register. This scale incorporates aspects referring to five 
situations: existence of a past history of falls, medication consumption, sensory deficits, mental 
status and ability to walk. Scores range from 0 to 11, with a score of 3 or more indicating a high 
risk of falls. 
  
Data analysis 
The software package IBM SPSS Statistics v.21.0 was used for data analysis. Quantitative 
variables were expressed as the mean and standard deviation (SD). Qualitative variables were 
expressed through frequency tables in absolute values and percentages. Between-group 
comparisons were made using a chi-square test for categorical variables and a Student's t-test for 
continuous variables. For proportions, Cohen's w values were reported as indicators of effect size 
(ES) and calculated as the square root of the ratio of the square of Pearson's contingency 
coefficient divided by one minus that square. We interpreted the importance of the ES using the 
benchmarks for ‘small ES’ (w = 0.1), ‘medium ES’ (w = 0.3) and ‘large ES’ (w = 0.5) for 
measuring the distance between unpaired proportions. Effect sizes for continuous variables are 
reported in terms of Cohen's d using the benchmarks for ‘small ES’ (d = 0.2), ‘medium ES’ 
(d = 0.5) and ‘large ES’ (d = 0.8). Both ES were proposed by Cohen (1988). 
 
For the independent variable age, two intervals (65–79 years vs. extremely elderly individual 
aged ≥80 years) were established based on population projections indicating that the number of 
extremely elderly octogenarians or older is rising quickly and the capacity at age 65 is very 
different from that at 80 (WHO 2015). For the independent variable, sex, masculine and feminine 
were used as references based on the expected results. A multiple forward stepwise logistic 
regression analysis (Wald method) was performed to identify which independent variables [19 
reported diseases – 14 from the CCI: coronary heart disease (including both myocardial infarct and 
congestive heart failure), peripheral vascular disease, cerebrovascular disease, dementia, chronic 
pulmonary disease, connective tissue disease, ulcer disease, mild liver disease, diabetes, 
hemiplegia, moderate or severe renal disease, diabetes with end-organ damage, any tumour, and 
moderate or severe liver disease; and 5 prevalent diagnoses – hypertension, rheumatic disorders, 
anxiety-depressive symptoms, dizziness/vertigo and digestive problems] modified the presence of 
polymedication. Three models were developed in the analysis: the first model included all the 
samples; the second model included only women; and the third model included only men. Odds 
ratios (OR) and 95% confidence intervals (CI) were calculated for each covariate included in the 
model. The level of significance was set to P < 0.05. 
Results 
A total of 742 telecare users (85.3% of all users) were included in the study. The participants 
had a mean length of use of 4 years, 11 months and 16 days from the activation of the service. 
Table 1 shows the sociodemographic characteristics, medication consumption, Downton index and 
presence of disability and/or dependence of the participants. The mean age was 83.3 (SD 6.6) 
years, and 85.8% of the participants were women. Of all subjects, 78.3% lived alone; 97.5% 
consumed at least one medication per day, with an average of 5.6 (SD 3.0) medications per day. 
Furthermore, of the subjects, 59.4% consumed five or more different medications per day and 
8.0% consumed 10 or more. A significant association (P = 0.004) was found between the number 
of medications consumed per day and age group. 
 
Table 1. Sociodemographic characteristics, medication consumption, Downton Index and presence of disability and/or dependence according to sex and age categorised into two groups (65–79 years 
and ≥80 years) 
  
Total 
(n = 742) 
Women 
(n = 637) 
Men 
(n = 105) 
P-value 
Effect size (Cohen's 
w/d) 
65–79 
(n = 209) 
≥80 
(n = 533) 
P-value 
Effect size (Cohen's 
w/d) 
Age, mean (SD) 83.3 (SD 6.6) 83.4 (SD 6.5) 83.0 (SD 7.2) 0.576 – 75.2 (SD 3.7) 86.5 (SD 4.5) <0.001*** 0.17 
Whom they live with (n, %) 
   
0.190 – 
  
0.500 – 
Alone (n, %) 575 (78.3) 500 (79.4) 75 (72.1) 
  
156 (76.1) 419 (79.2) 
  
With relatives (n, %) 152 (20.7) 123 (19.5) 29 (27.9) 
  
48 (23.4) 104 (19.7) 
  
With someone other than relatives (n, %) 4 (0.5) 0 (0.0) 4 (0.6) 
  
1 (0.5) 3 (0.6) 
  
Number of medications, mean (SD) 5.6 (SD 3.0) 5.6 (SD 3.0) 5.3 (SD 2.7) 0.354 – 6.2 (SD 3.3) 5.4 (SD 2.8) 0.004** 0.50 
Medication consumption (n, %) 703 (97.5) 605 (97.7) 98 (96.1) 0.319 – 195 (97.0) 508 (97.7) 0.601 – 
Polymedicated users (five or more medications, n, 
%) 
441 (59.4) 380 (59.7) 61 (58.1) 0.763 – 132 (63.2) 309 (58.0) 0.196 – 
Polymedicated users (10 or more medications, n, 
%) 
59 (8.0) 53 (8.3) 6 (5.7) 0.360 – 27 (12.9) 32 (6.0) 0.002** 0.11 
Downton Index, mean (SD) 2.3 (SD 1.4) 2.4 (SD 1.4) 2.2 (SD 1.5) 0.456 – 2.3 (SD 1.4) 2.4 (SD 1.5) 0.093 – 
History of falls (n, %) 294 (40.4) 252 (40.4) 42 (40.4) 0.049* 0.09 81 (39.5) 213 (40.7) 0.781 – 
Disability (n, %) 210 (51.3) 181 (51.0) 29 (53.7) 0.710 – 65 (51.2) 145 (51.4) 0.965 – 
Dependence (n, %) 81 (17.9) 67 (17.2) 14 (22.2) 0.332 – 21 (14.8) 60 (19.3) 0.246 – 
          
 
*P < 0.05; **P < 0.01; ***P < 0.001 (t-test for means and χ2 for percentages). 
 
 
 
 
The mean score of the Downton index was 2.3 (SD 1.4). Users with a risk of falls or who had 
already fallen represented 40.4% of the total. Among these users, both genders reported a similar 
number of previous falls (40.4%) and this relationship between sex and history/risk of falls was 
significant (P = 0.049). Based on the calculation of the risk of falls with the Downton Fall Risk 
Index, subjects at severe risk of falling represented 41.7% of the sample, and disabled people 
presented a 2.4 times (95% CI, 1.61–3.64) higher risk of falling (P < 0.001). 
 
Of the participants, 51.3% had some type of disability, with physical disability being the most 
common type. Moreover, 17.9% of the sample depended on others to carry out at least one basic 
activity of daily living. There were no significant differences in the variables between the genders. 
With regard to medical diagnosis, the mean CCI score was 1.1 (SD 1.1). Of the sample, 68.2% 
did not have a comorbid condition (CCI = 0), 21.1% had a low level of comorbidity (CCI = 2) and 
10.6% had a high level of comorbidity (CCI ≥ 3). 
 
Table 2 shows the most frequent diagnosis according to sex and age group (65–79 vs. ≥80) and 
their possible association. The most frequently reported pathology was hypertension (HTN) 
(51.1%), followed by rheumatic disorders (44%) and coronary heart disease (34.7%). An 
association was found between masculine gender and coronary heart disease (P = 0.002), dementia 
(P = 0.011), ulcer disease (P = 0.003), diabetes (P = 0.038) and moderate or severe renal disease 
(P = 0.012) and between feminine gender and rheumatic disorders (P < 0.001). A significant 
association was found between the age groups and the medical diagnosis. Peripheral vascular 
disease (P = 0.020) increased with age, while anxiety-depressive symptoms (P = 0.013), chronic 
pulmonary disease (P = 0.007), connective tissue disease (P = 0.006), hemiplegia (P < 0.001) and 
moderate or severe liver disease (P = 0.033) showed a decreasing trend. However, the clinical 
significance of these results was low or very low, with small to very small effect sizes (Cohen's w 
values).
Table 2. Diagnosis (n, %, ordered by their prevalence in the studied sample) according to sex and age categorised into two groups (65–79 years and ≥80 years) and their possible association 
Pathology No. of subjects 
General 
 prevalence 
Sex 
 
Age (years) 
Women Men P-value Effect size (Cohen's w) 
 
65–79 ≥80 P-value Effect size (Cohen's w) 
 
 
Hypertension 666 340 (51.1) 295 (86.8) 45 (13.2) 0.376 –  89 (26.2) 251 (73.8) 0.198 – 
Rheumatic disorders (Osteoporosis and arthrosis) 657 289 (44.0) 267 (92.4) 22 (7.6) <0.001*** 0.17  77 (26.6) 212 (73.4) 0.444 – 
Coronary heart disease 665 231 (34.7) 184 (79.7) 47 (20.3) 0.002** 0.12  64 (27.7) 167 (72.3) 0.962 – 
Anxiety-depressive symptoms 663 166 (25.0) 149 (89.8) 17 (10.2) 0.093 –  59 (35.5) 107 (64.5) 0.013* 0.10 
Diabetes 665 130 (19.5) 104 (80.0) 26 (20.0) 0.038* 0.08  45 (34.6) 85 (65.4) 0.081 – 
Peripheral vascular disease 659 107 (16.2) 91 (85.0) 16 (15.0) 0.785 –  20 (18.7) 87 (81.3) 0.020* 0.09 
Dizziness/Vertigo 270 41 (15.2) 40 (97.6) 1 (2.4) 0.055 –  12 (29.3) 29 (70.7) 0.596 – 
Chronic pulmonary disease 661 78 (11.8) 67 (85.9) 11 (14.1) 0.975 –  32 (41.0) 46 (59.0) 0.007** 0.10 
Digestive problems 660 77 (11.7) 63 (81.8) 14 (18.2) 0.293 –  19 (24.7) 58 (75.3) 0.505 – 
Cerebrovascular disease 660 54 (8.2) 45 (83.3) 9 (16.7) 0.595 –  19 (35.2) 35 (64.8) 0.211 – 
Connective tissue disease 659 41 (6.2) 37 (90.2) 4 (9.8) 0.394 –  19 (46.3) 22 (53.7) 0.006** 0.11 
Any tumour 655 33 (5.0) 27 (81.8) 6 (18.2) 0.520 –  14 (42.4) 19 (57.6) 0.057 – 
Hemiplegia 660 12 (1.8) 9 (75.0) 3 (25.0) 0.282 –  10 (83.3) 2 (16.7) <0.001*** 0.17 
Dementia 659 6 (0.9) 3 (50.0) 3 (50.0) 0.011* 0.10  2 (33.3) 4 (66.7) 0.767 – 
Moderate or severe liver disease 660 6 (0.9) 5 (83.3) 1 (16.7) 0.864 –  4 (66.7) 2 (33.3) 0.033* 0.08 
Moderate or severe renal disease 661 6 (0.9) 3 (50.0) 3 (50.0) 0.012* 0.10  2 (33.3) 4 (66.7) 0.770 – 
Diabetes with end organ damage 660 5 (0.8) 3 (60.0) 2 (40.0) 0.098 –  2 (40.0) 3 (60.0) 0.544 – 
Mild liver disease 660 5 (0.8) 5 (100.0) 0 (0.0) 0.360 –  1 (20.0) 4 (80.0) 0.693 – 
Ulcer disease 656 5 (0.8) 2 (40.0) 3 (60.0) 0.003** 0.11  2 (40.0) 3 (60.0) 0.545 – 
            
 
*P < 0.05; **P < 0.01; ***P < 0.001 (χ2 for percentages). 
 
 
Table 3 shows the medications distributed by classes according to the EphMRA classification 
as well as their possible association with sex and age group. The groups of medications that were 
not consumed by any user are not represented. Of the subjects, 75% consumed medications 
included in the cardiovascular system group; 65.2% included in the central nervous system group 
and 63.9% included in the alimentary tract and metabolism group. A significant association 
(P < 0.001) was found between feminine gender and the consumption of medications included in 
the central nervous system group and between masculine sex and the consumption of medications 
targeting the genito-urinary system (P < 0.001). With regard to age, an association was found 
between younger age and the consumption of different medications, such as those acting on the 
alimentary tract and metabolism (P = 0.014) and respiratory system (P = 0.001). Furthermore, 
medications acting on the cardiovascular system (P = 0.014) were more often consumed by older 
subjects. However, the clinical significance of these results was low or very low, with small to 
very small effect sizes (Cohen's w values). 
Table 3. Medications consumed (n, %, ordered by frequency of consumption in the total sample) and their possible 
relationships with the variables sex and age categorised into two groups, 65–79 years and ≥80 years 
Medication class 
Sex 
 
Age (years) 
Total Women Men P-value 
Effect size 
(Cohen's w) 
 
65–79 ≥80 P-value 
Effect size 
(Cohen's w) 
 
 
Cardiovascular system 
540 
(75.0) 
464 
(75.1) 
76 
(74.5) 
0.902 – 
 138 
(68.7) 
402 
(77.5) 
0.014* 0.09 
Nervous system 
469 
(65.2) 
420 
(68.1) 
49 
(48.0) 
<0.001*** 0.15 
 138 
(69.0) 
331 
(63.8) 
0.188 – 
Alimentary tract and 
metabolism 
457 
(63.9) 
391 
(63.8) 
66 
(64.7) 
0.858 – 
 142 
(71.0) 
315 
(61.2) 
0.014* 0.09 
Blood and blood-forming 
organs 
430 
(60.0) 
360 
(58.5) 
70 
(68.6) 
0.054 – 
 128 
(64.3) 
302 
(58.3) 
0.141 – 
Musculo-skeletal system 
139 
(19.4) 
121 
(19.6) 
18 
(17.8) 
0.673 – 
 41 
(20.4) 
98 
(19.0) 
0.661 – 
Respiratory system 
77 
(10.7) 
67 
(10.9) 
10 
(9.8) 
0.746 – 
 34 
(16.9) 
43 (8.3) 0.001** 0.12 
Genito-urinary system 
and sex hormones 
53 (7.4) 31 (5.0) 
22 
(21.6) 
<0.001*** 0.22 
 
13 (6.5) 40 (7.8) 0.551 – 
Sensory organs 45 (7.0) 39 (6.9) 6 (7.5) 0.844 –  13 (7.3) 32 (6.9) 0.860 – 
Dermatologicals 8 (1.1) 8 (1.3) 0 (0.0) 0.247 –  1 (0.5) 7 (1.4) 0.326 – 
           
 
*P < 0.05; **P < 0.01; ***P < 0.001 (χ2 for percentages). 
Finally, a multiple logistic regression analysis (Table 4) selected the best determinants of 
polymedication (five or more prescribed medications). For the total sample, the three main 
determinants were hypertension (P < 0.001), anxiety-depressive symptoms (P = 0.028) and 
coronary heart disease (P = 0.009). The OR were 3.50 for hypertension, 2.10 for anxiety-
depressive symptoms and 2.30 for coronary heart disease. This model accurately predicted 67.3% 
of the cases at risk of consuming five or more medications. The best determinants for women were 
also hypertension (P < 0.001) and coronary heart disease (P = 0.002), with 71.3% of cases of 
polymedication (≥5) correctly predicted. The OR were 3.59 for hypertension and 3.10 for coronary 
heart disease. For men, no determinants were identified.  
Table 4. Logistic regression of major predictor diseases and presence of polymedication (≥5 prescription medications) 
 
Total 
 
Women 
 
Men 
Odds ratio  
(95% CI) 
P-value 
 Odds ratio  
(95% CI) 
P-value 
 Odds ratio  
(95% CI) 
P-value 
  
 
Hypertension 
3.504 (2.006–
6.122)*** 
<0.001 
 3.588 (1.988–
6.476)*** 
<0.001 
 
– – 
Anxious-depressive symptoms 
2.095 (1.085–
4.047)* 
0.028 
 
– – 
 
– – 
Coronary heart disease 
2.299 (1.227–
4.305)** 
0.009 
 3.098 (1.527–
6.286)** 
0.002 
 
– – 
% Correct 67.3 
 
 71.3 
 
 – 
 
         
 
% Correct: Percentage correctly classified. 
*P < 0.05; **P < 0.01; ***P < 0.001. 
Discussion 
The information and communication technologies, such as the first-generation telecare 
discussed in this work, can help people to remain at home longer (Botsis et al. 2008, Kubitschke 
et al. 2010, Galimany-Masclans et al. 2011), improving the user's and caregiver's quality of life 
and avoiding institutionalisation in many cases. Moreover, telecare services provide both an 
adequate substitution for traditional services and additional benefits, such as minimising the need 
to travel and providing the added reassurance of regular external surveillance (Rogers et al. 2011). 
However, for telecare to fulfil its function, it is necessary to know the profile of the ‘potential 
beneficiary’ in advance to determine the characteristics of the future service and thus, improve its 
efficiency. In this sense, our work, with a prospective vision, attempts to define the user's profile 
while taking into account health aspects, which are often ignored and, according to our findings, 
highly important for accurately evaluating the effects of the service. The different profile and 
needs of elderly people will vary the benefits and cost-effectiveness of telecare (Henderson et al. 
2014). Impact will be also observed in the health and social care system (Odeh et al. 2015) due to 
the amelioration in the decline of some psychological aspects and quality of life (Hirani et al. 
2014). 
 
With respect to the sample's sociodemographic profile, our findings are consistent with other 
studies, showing that users are of advanced age, generally over 80 years, and mainly women (Onor 
et al. 2008, Peeters et al. 2012, IMSERSO, 2014). A high percentage of these older adults live 
alone (78.3%), as found in other studies (Onor et al. 2008, Peeters et al. 2012) of telecare users. 
However, predictably, according to the service prioritisation conditions, the percentage is 
substantially higher than that for the general population, which in the case of the Spanish 
population, represents 37.9% (IMSERSO 2014). 
 
The rate of disability (51.3%) is in line with the rate from the Survey on Disability, Personal 
Autonomy and Dependence Situations (EDAD; Spanish Statistical Office [Instituto Nacional de 
Estadística] 2008), which establishes that 30.3% of people over 65 have a disability. However, the 
rate is ostensibly higher than those included in Gispert Magarolas et al.'s (2009) work, which were 
obtained from the general population. In regard to dependence, 17.9% of subjects are dependent; 
this percentage is in line with the EDAD Survey (Spanish Statistical Office [Instituto Nacional de 
Estadística] 2008), which reports that 19% of the Spanish population are dependent, and is similar 
to those reported by studies in the USA (Kim et al. 2013) and Ireland (McDaid et al. 2013). 
However, this percentage is lower than that found by Millán-Calenti et al. (2010) for the Galician 
population, as they found that 34.6% of their participants were dependent on others for at least one 
basic activity of daily living and that these participants were more frequently women. These 
results can be explained by the different origins of the samples, i.e. telecare users versus the 
general population. As expected, as the level of disability, dependence and comorbidity increases, 
the number of multigenerational households increases (Abellán-García & Ayala-García 2011). 
 
The figures found by different studies vary in relation to various factors, such as the sample's 
origin, the data collecting system, and sex and age, among others. However, if we focus on health 
aspects, our work shows the high prevalence of chronic and incapacitating illnesses, reaching a 
mean comorbidity of 2.8 (SD 1.7) per subject, which matches other consulted studies (Peeters 
et al. 2012). This highlights the non-compliance of the first-generation systems, which mainly 
aimed to alleviate the social situation, and the need to implement more advanced systems that 
allow for the assessment and monitoring of some diagnosed chronic diseases, such as heart failure, 
diabetes and chronic obstructive pulmonary disease, among other chronic diseases (Greenhalgh 
et al. 2013). 
 
Regarding type of diagnosed pathology, the results from the National Health Survey (Spanish 
Statistical Office [Instituto Nacional de Estadística] 2013b) indicate the prevalence of perceived 
chronic illnesses or health problems in Spain. Specifically, the survey reports that 73.4% of 
subjects aged 65 and over have at least one problem. The survey reports a lower prevalence than 
the current study for acute myocardial infarction and coronary diseases (16.9 vs. 34.7%) and the 
COPD (10.1 vs. 11.8%) and a higher prevalence for HTN (47.1 vs. 51.1%) and peripheral vascular 
disease (23.8 vs. 16.2%). Telehealth has demonstrated to improve the self-management of 
hypertension and control of blood pressure in elderly patients (Czaja et al. 2014, Jung & Lee 
2017). Diabetes shows similar figures (19.3 vs. 19.5%). There are also differences in regard to sex, 
with coronary heart disease more often found in men than in women and found in higher 
proportion in the current study compared to other studies (Salminen et al. 2012). A multi-centre 
randomised controlled trial with patients with coronary artery disease or chronic heart failure has 
demonstrated that cardiac telerehabilitation adds positive effects and efficiency to the conventional 
centre-based cardiac rehabilitation programme, reducing the number of hospitalisation days and 
increasing the days alive and out of the hospital (Frederix et al. 2016). Concerning diabetes, some 
studies (Steinman et al. 2006, Bertera et al. 2007) indicate higher total rates and higher rates 
among men, but others, such as Griffith et al. (2010) and McDaid et al. (2013), submit lower 
figures. As previously stated, these figures can be explained based on the studied sample, which in 
our case, included ‘healthy’ subjects with sociosanitary problems, causing the figure to differ from 
those obtained from surveys of healthy populations or collected in a health setting, such as the 
National Health Survey carried out in Spain for the years 2011–2012 (Spanish Statistical Office 
[Instituto Nacional de Estadística] 2013a). Regarding anxiety-depressive symptoms, the results 
found in the literature vary, mainly according to the origin of the sample and the instruments used 
in the assessment (Onor et al. 2008, Spanish Statistical Office [Instituto Nacional de Estadística] 
2013a), but in general, the results typically show a higher prevalence among women than among 
men (Herrera Molina et al. 2011). Lastly, telecare has also demonstrated its utility in the provision 
of rheumatology services with an impact in the care costs (Jang & Kraishi 2004), being the main 
contribution the improved access to doctors for patients and their referring physicians living in 
remote areas (Davis 2003). A multidisciplinary osteoporosis telehealth programme has 
demonstrated its adequacy for ensuring an optimal osteoporosis care (Dickson et al. 2008). 
 
Concerning medication consumption, the Spanish National Health Survey (Spanish Statistical 
Office [Instituto Nacional de Estadística] 2013b) finds that more than 83.3% of people over 
65 years consume medications, with women showing high levels of consumption. In our series, 
97.5% of the subjects consumed at least one medication, with a mean daily consumption of 5.6 
(SD 3.0) medications and a great proportion of polymedicated subjects (≥5 medications/day) 
(59.4%). Similar figures are reported by other studies (IMSERSO 2014), with the resulting risk of 
therapeutic non-compliance, risk of falls and increase in morbidity and mortality (Márquez 
Contreras et al. 2012). Because 35% of telecare users are expected to have poor pharmacological 
adherence (WHO 2004), it would be advisable to start or encourage strategies that improve 
therapeutic compliance, such as, in the case of telecare, the regularly scheduled telephone call. 
 
Our results regarding the type of medication consumed by main groups (EphMRA, 2014) are 
similar to those from other authors (Jyrkkä et al. 2009, Lapi et al. 2009) that establish that the 
most frequently prescribed categories of medication have effects on the cardiovascular, metabolic 
and central nervous systems. Furthermore, hypertension, anxiety-depressive symptoms and 
coronary disease were the best determinants of polymedication for the total sample, and 
hypertension and coronary heart disease were the best determinants among women. These results 
are consistent with other studies linking polypharmacy to comorbidity (Galato et al. 2010, Sergi 
et al. 2011, Gnjidic et al. 2012), but our study establishes a new approach because we examine the 
predictive pathology of polymedication rather than simply the existence of associations. 
Concomitantly, the identification of medication consumed and the comorbidity level could be an 
effective way to identify frailty (Coelho et al. 2015) because telecare could be particularly useful 
to frail elderly people (Barlow et al. 2007). 
 
Falls, with a high prevalence among elderly people, imply high levels of morbidity and 
mortality (Salvà et al. 2004) and are an under-diagnosed problem (Pujiula Blanch et al. 2003, 
Varas-Fabra et al. 2006). The most effective fall prevention strategy is multidimensional 
assessment, including the consumption of psychotropic medications (Moreno-Martínez et al. 
2005). In our study, a high percentage of subjects presented a high risk of falls; therefore, the 
implementation of more advanced telecare models, such as those implemented in the United 
Kingdom (Yeandle 2009), could reduce incidence, severity and associated costs of falls. 
Strengths and limitations 
Our study is the first to attempt to define the social and health characteristics of the users of a 
first-generation telecare service in Spain, and the data provided can serve as a reference for other 
studies, which is the study's main strength. The review by Botsis and Hartvigsen (2008) found that 
many studies focused on telecare for elderly people had a small sample. Therefore, another 
strength of the current study is the large sample size used. 
 
The study's main limitation is the lack of similar international studies, as such studies would 
allow us to contrast our results rather than comparing them with results from general populations 
or populations assisted by the health systems but not specifically telecare users. Overall, we 
understand that this study lays the foundation to better equip telecare systems to adequately meet 
the needs of their potential users, who are normally old aged, female, living alone, suffering from 
several chronic diseases and consuming various medications. Moreover, some findings should be 
interpreted with caution because there were very small or small effect sizes. Finally, the 
determinants proposed have been identified using stepwise method in an exploratory analysis and 
this procedure has limitations, i.e. the increased risk of unimportant determinants or 
inconsistencies among model selection algorithms (Whittingham et al. 2006) that do not report the 
real response in the population and may result in overfitting (Babyak 2004). 
Conclusions and implications for practice 
In conclusion, independent of the social elements contributing to the implementation of 
telecare services, the important health characteristics of the users are evident, including morbidity 
and polypharmacy. Moreover, the characteristics of the studied population of users of a telecare 
system may be useful in regard to designing systems to meet the users’ needs. We understand that 
telecare services should be adapted both in regard to the specialisation of the service professionals, 
who should be both health promoters and advisors, and the portfolio of services offered, which 
should allow the inclusion of third-generation devices to control and monitor patients with chronic 
illnesses. Therefore, this resource, if widely disseminated, may help to clear the sociosanitary 
system, improve the quality of life of the older person and decrease the burden on the family 
caregiver. 
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